注册现已开放阿托撒Therapeutics的部落公共研讨会万博manbetx 体育官网演讲和2020年Q&A活动10月13日,

阿托撒标志

PDF打印查看全部
注册现已开放阿托撒Therapeutics的部落公共研讨会万博manbetx 体育官网演讲和2020年Q&A活动10月13日,
在十月乳腺癌宣传月的荣誉,阿托撒的CEO史蒂芬博士码头,医学博士,博士&CFO凯尔固涩将提供一个题为“阿托撒治疗:应对我们的最大健康威胁 - COVID-19和乳腺癌”万博manbetx 体育官网万博体育怎么买足彩

西雅图,2020年10月7日(GLOBE NEWSWIRE) - 阿托撒治疗公司(纳万博manbetx 体育官网斯达克股票代码:ATOS),临床阶段的生物制药公司寻求与当前的重点是乳腺癌发现和开发中的显著未满足的医疗需求领域创新药物and COVID-19, announces that Atossa’s CEO, Dr. Steven Quay, M.D., Ph.D. & CFO, Kyle Guse, Esq., will present at Tribe Public’s Zoom Webinar Presentation and Q&A Event scheduled to begin at 8am Pacific/11am Eastern on Tuesday, October 13。要注册参加免费的,有限的容量基于ZOOM-事件,请访问部落公共LLC在Atossa.TribePublic.com。注册后,参与者可以开始转发他们的问题对阿托撒的管理层部落公众HTTP://research@tribepublic.com或通过在活动期间ZOOM聊天功能份额。

在这个免费的30分钟的活动,阿托撒的管理团队将提供一个题为,阿托撒治疗:应对我们的最大健康威胁 - COVID-19与乳腺癌万博体育怎么买足彩CancerA Q&A session will follow regarding Atossa’s breast cancer development programs and recent progress with its two COVID-19 treatment programs, including AT-301, a nasal spray treatment therapy being developed to potentially help prevent COVID-19 infection, particularly for people in high risk communities and those working in higher-risk areas, including healthcare workers, emergency responders and teachers. Tribe Public’s Managing Member, John F. Heerdink, Jr., will host the event and relay all questions.

史蒂芬码头,医学博士,博士是总部位于西雅图的阿托撒Therapeutics公司的创始人(纳万博manbetx 体育官网斯达克股票代码:ATOS)。他的医学博士学位,博士来自密歇根大学,在化学系在麻省理工学院诺贝尔奖得主H.戈宾德科拉纳,居民在哈佛大学麻省总医院医院做博士后,花了近十年的斯坦福大学医学院的教授。他对医学的贡献被引用9,890次。他公司成立六年的创业,发明了7 FDA批准的药品,并拥有87项美国专利。超过80万人从他发明的药物中受益。他目前的心情是解决大医疗问题:停止COVID-19大流行,每年防止两百万乳腺癌病例在世界上。万博体育怎么买足彩码头博士最近出版的和高度赞誉题为书“保持安全:医生的指南,让您和您的家人健康的流感大流行期间及以后”可在他的网站http://www.drquay.com/books

关于阿托撒T万博manbetx 体育官网HERAPEUTICS

总部位于西雅图的阿托撒The万博manbetx 体育官网rapeutics公司是一家临床阶段的生物制药公司寻求发现和发展的显著未满足的医疗需求领域创新药物与当前的重点是乳腺癌和COVID-19。万博体育怎么买足彩欲了解更多信息,请访问:www.www.compemergency.com

关于TRIBE PUBLIC LLC

Tribe Public LLC is a San Francisco, CA based organization that hosts complimentary worldwide webinar & meeting events in the U.S. Tribe’s complimentary events focus on issues that the Tribe members care about with an emphasis on hosting experts and CEO’s of from publicly traded NYSE and Nasdaq listed companies from all sectors & financial organizations that are seeking to increase awareness of their products, progress and plans. Tribe members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, & Accredited Investors from more than 15 countries. Tribe members submit their collective interests via Tribe’s complimentary “Wish List” process in order gain the understanding that they are seeking about the industries that care about. Join Tribe Public at Website:http://www.tribepublic.com/

前瞻性声明

前瞻性本新闻稿中,该阿托撒没有义务更新语句,都受到风险和不确定性,可能导致实际结果与预期或估计未来的结果有重大差异,包括与以下有关的风险和不确定性:是否体外测试结果也将在实现体内研究,包括人类临床研究,通过行动和与FDA,其结果或阿托撒需要监管部门的批准,包括那些开始AT-301的人体临床研究和这样的审判结果所需要的时间的互动,不是病人的预期率降低enrollment, the safety and efficacy of Atossa’s product candidates, performance of developers and manufacturers, clinical research organizations and investigators, obstacles resulting from proprietary rights held by others such as patent rights, uncertainties affecting our ability to secure patent protection for AT-301 or AT-H201 and other risks detailed from time to time in Atossa’s filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.

公司联系方式:
万博manbetx 体育官网阿托撒Therapeutics公司
凯尔固涩,财务总监,总法律顾问
办公室:(866)893-4927
kyle.guse@atossainc.com

投资者关系联系方式:
核心IR
办公室:(516)222-2560
ir@atossainc.com

来源:阿托撒Th万博manbetx 体育官网erapeutics公司

主要标志

2020年10月7日

隐私

字体调整大小